obesity drug news today glp-1 october 21 2025 The popularity of drugs has exploded. Once a relatively obscure class of drugs prescribed for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects The Age of Oral GLP-1s

Diabetologia 60 , 17311739 (2017)

Additionally, given that the CPRD is a general practice database, prescriptions written by specialists are not captured, which may be another source of exposure misclassification

These medications help control blood sugar and reduce appetite by mimicking the bodys natural GLP-1 hormone

[DOI] [PubMed] [Google Scholar] 106.Shimazu-Kuwahara S, Harada N, Yamane S, Joo E, Sankoda A, et al

The morning protocol Wake up

Diabetes Obes Metab 22(12):24872492 Verma S, Bhatta M, Davies M, Deanfield JE, Garvey WT, Jensen C, et al (2023) Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials